Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Tessa Receives PRIME Designation from EMA for CD30 CAR-T Therapy

americanpharmaceuticalreviewJanuary 27, 2021

Tag: Tessa , PRIME , EMA , CD30 CAR-T therapy

PharmaSources Customer Service